Ariel Investments LLC Has $149.49 Million Stock Position in Core Laboratories Inc. $CLB

Ariel Investments LLC lifted its position in shares of Core Laboratories Inc. (NYSE:CLB) by 25.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,976,463 shares of the oil and gas company’s stock after acquiring an additional 2,634,438 shares during the quarter. Core Laboratories makes up about 1.7% of Ariel Investments LLC’s investment portfolio, making the stock its 28th largest position. Ariel Investments LLC owned approximately 27.67% of Core Laboratories worth $149,489,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in CLB. Hotchkis & Wiley Capital Management LLC acquired a new stake in Core Laboratories in the first quarter worth about $6,008,000. Fred Alger Management LLC boosted its stake in shares of Core Laboratories by 32.4% in the 1st quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company’s stock valued at $11,045,000 after purchasing an additional 180,344 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Core Laboratories during the 1st quarter worth approximately $2,573,000. Arkadios Wealth Advisors acquired a new stake in shares of Core Laboratories during the 2nd quarter worth approximately $978,000. Finally, Russell Investments Group Ltd. raised its stake in shares of Core Laboratories by 29.6% during the second quarter. Russell Investments Group Ltd. now owns 196,992 shares of the oil and gas company’s stock worth $2,269,000 after buying an additional 44,949 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Trading Up 2.3%

Shares of NYSE CLB opened at $16.81 on Wednesday. The company’s fifty day moving average is $14.43 and its 200-day moving average is $12.67. The stock has a market cap of $782.44 million, a price-to-earnings ratio of 25.08, a P/E/G ratio of 15.00 and a beta of 1.08. Core Laboratories Inc. has a twelve month low of $9.72 and a twelve month high of $20.82. The company has a quick ratio of 1.76, a current ratio of 2.37 and a debt-to-equity ratio of 0.41.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, October 22nd. The oil and gas company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. The business had revenue of $134.52 million during the quarter, compared to analysts’ expectations of $130.92 million. Core Laboratories had a net margin of 6.21% and a return on equity of 12.85%. The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.25 EPS. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. Equities research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 24th. Stockholders of record on Monday, November 3rd were issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Monday, November 3rd. Core Laboratories’s payout ratio is 5.97%.

Wall Street Analysts Forecast Growth

CLB has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Core Laboratories in a research note on Monday. Zacks Research raised Core Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, August 15th. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $12.50.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.